title: Enthusiasm for antibody-drug conjugates.
authors.forename: Rabiya S
authors.initials: RS
authors.lastname: Tuma
mesh_terms: D000080044:Ado-Trastuzumab Emtansine; D000617:Aminoglycosides / Q000494:pharmacology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D000079963:Brentuximab Vedotin; D017326:Clinical Trials, Phase III as Topic; D017277:Drug Approval; D000079982:Gemtuzumab; D006801:Humans; D018796:Immunoconjugates / Q000494:pharmacology* / Q000627:therapeutic use*; D000080045:Inotuzumab Ozogamicin; D008453:Maytansine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D000068878:Trastuzumab
chemical_list: D000617:Aminoglycosides; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018796:Immunoconjugates; D008453:Maytansine; D000079963:Brentuximab Vedotin; D000079982:Gemtuzumab; D000068878:Trastuzumab; D000080045:Inotuzumab Ozogamicin; D000080044:Ado-Trastuzumab Emtansine